Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | CASR | P41180 | 2/20 | 0.48 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.47 |
| ▸ | PLA2G2C | Q5R387 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11596086 | 1.00 | USP2 (0.58) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL15422990 | 0.94 | USP2 (0.55) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL4136001 | 0.93 | USP2 (0.51) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL11575291 | 0.92 | USP2 (0.50) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL11575286 | 0.92 | USP2 (0.50) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL4794303 | 0.88 | USP2 (0.58) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL23615821 | 0.84 | USP2 (0.57) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL10429392 | 0.84 | USP2 (0.56) | USP2HTTCASRLPAR5CYP1A2 | |
| SCHEMBL4135996 | 0.82 | USP2 (0.51) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL23615802 | 0.80 | CASR (0.51) | USP2HTTCASRLPAR5PLA2G2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020250966-A1 | EMULSION COMPOSITION | 花王株式会社 | 2020-12-17 | — | — | WO | disclosed |
| US-9694076-B2 | Vesicle composition | KAO CORPORATION (JP) | 2017-07-04 | — | — | US | disclosed |
| US-9694076-B2 | Vesicle composition | KAO CORPORATION (JP) | 2017-07-04 | — | — | US | disclosed |
| US-20160166698-A1 | VESICLE COMPOSITION | KAO CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160166698-A1 | VESICLE COMPOSITION | KAO CORPORATION (JP) | 2016-06-16 | — | — | US | disclosed |
| US-9278059-B2 | Emulsified cosmetic composition | KAO CORPORATION (JP) | 2016-03-08 | — | — | US | disclosed |
| US-9278059-B2 | Emulsified cosmetic composition | KAO CORPORATION (JP) | 2016-03-08 | — | — | US | disclosed |
| EP-2692334-B1 | VESICLE COMPOSITION | KAO CORP (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-20150133550-A1 | Emulsified Cosmetic Composition | KAO CORPORATION (JP) | 2015-05-14 | — | — | US | disclosed |
| US-20150133550-A1 | Emulsified Cosmetic Composition | KAO CORPORATION (JP) | 2015-05-14 | — | — | US | disclosed |
| US-20120295989-A1 | OIL-BASED COMPOSITION | KAO CORPORATION (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20120295989-A1 | OIL-BASED COMPOSITION | KAO CORPORATION (JP) | 2012-11-22 | — | — | US | disclosed |
| EP-2520275-A1 | OIL-BASED COMPOSITION | Kao Corporation (JP) | 2012-11-07 | — | — | EP | disclosed |
| US-8178584-B2 | Sphingosines, fatty acid, and oil; improved stability and feel to skin | KAO CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178584-B2 | Sphingosines, fatty acid, and oil; improved stability and feel to skin | KAO CORPORATION (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20100311836-A1 | OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2010-12-09 | — | — | US | disclosed |
| US-20100311836-A1 | OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2010-12-09 | — | — | US | disclosed |
| US-7846969-B2 | Ceramide emulsions | KAO CORPORATION (JP) | 2010-12-07 | — | — | US | disclosed |
| US-7846969-B2 | Ceramide emulsions | KAO CORPORATION (JP) | 2010-12-07 | — | — | US | disclosed |
| EP-1486194-B1 | Oil-in-water emulsified cosmetic composition | KAO CORP (JP) | 2010-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120295989-A1 | OIL-BASED COMPOSITION | SGMS1, SGMS2, F12 | USP2 3763/4885HTT 4324/4885CASR 4666/4885 |
| US-20160166698-A1 | VESICLE COMPOSITION | SGMS1, EXOSC10, SGMS2 | USP2 3794/4885HTT 4714/4885CASR 827/4885 |
| US-20100311836-A1 | OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION | CERT1, SGMS1, DEGS1 | USP2 3447/4885HTT 2149/4885CASR 3959/4885 |
| US-20150133550-A1 | Emulsified Cosmetic Composition | SGMS2, SGMS1, DEGS1 | USP2 3859/4885HTT 3166/4885CASR 3603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.